−Removed: Unregistered Sales of Equity Securities and Use of Proceeds.
+Added: Unregistered Sales of Equit y Securities and Use of Proceeds.
Recent Sales of Unregistered Securities
−Removed: Other than as reported in a Current Report on Form 8-K, we did not sell any securities that were not registered under the Securities Act during the three months ended September 30, 2020.
+Added: We did not sell any securities that were not registered under the Securities Act during the three months ended March 31, 2021.
Use of Proceeds from Initial Public Offering
9 unchanged sentences
None of the underwriting discounts and commissions or offering expenses were incurred or paid to directors or officers of ours or their associates or to persons owning 10% or more of our common stock or to any of our affiliates.
−Removed: We have used approximately $26.5 million of the net proceeds from the IPO as of September 30, 2020 to fund the clinical development of losmapimod, to advance our pipeline of clinical-stage and preclinical product candidates, and to research and develop additional preclinical product candidates using our platform, and for working capital and other general corporate purposes.
+Added: We have used all of the net proceeds from the IPO as of March 31, 2021 to fund the clinical development of losmapimod, to advance our pipeline of clinical-stage and preclinical product candidates, and to research and develop additional preclinical product candidates using our platform, and for working capital and other general corporate purposes.
We have invested the unused net proceeds from the offering in cash equivalents and marketable securities.
10 unchanged sentences
Under the Plans
−Removed: July 1, 2020 through July 31, 2020
−Removed: August 1, 2020 through August 31, 2020
−Removed: September 1, 2020 through September 30, 2020
+Added: January 1, 2021 through January 31, 2021
+Added: February 1, 2021 through February 28, 2021
+Added: March 1, 2021 through March 31, 2021
Represents shares of unvested common stock that were repurchased by us from certain former employees upon termination of employment in accordance with the terms of the applicable employee's restricted stock agreement.
We repurchased the shares from the former employees at the original purchase price.
−Removed: Collaboration and License Agreement, dated as of July 20, 2020, by and between the Registrant and MyoKardia, Inc.
−Removed: First Amendment to the Right of Reference and License Agreement, dated as of September 23, 2020, by and among the Registrant, GlaxoSmithKline Intellectual Property (No.
−Removed: 2) Limited, GlaxoSmithKline LLC and Glaxo Group Limited.
+Added: Employment Agreement, dated F ebruary 6, 2021 , by and between the Registrant and Christopher Moxham.
+Added: Employment Agreement, dated March 19, 2021, by and between the Registrant and Judith Dunn.
+Added: Consulting Agreement, dated March 31, 2021, by and between the Registrant and Robert J.
+Added: Employment Agreement, dated March 31, 2021, by and between the Registrant and Bryan Stuart.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Certain portions of this exhibit have been omitted because they are not material and would likely cause competitive harm to the Registrant if disclosed.
Filed herewith.
2 unchanged sentences
FULCRUM THERAPEUTICS, INC.
−Removed: November 10, 2020
−Removed: /s/ Robert J.
−Removed: Chief Executive Officer and President, Director
−Removed: November 10, 2020
/s/ Bryan Stuart
−Removed: Chief Operating Officer (Principal Financial Officer)
+Added: Chief Executive Officer and President, Director
+Added: /s/ Peter Thomson
+Added: Peter Thomson
+Added: Vice President, Finance and Accounting (Principal Financial Officer and Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.